QA: Allergan Finance LLC in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000884629_2012_Allergan_Finance_LLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Allergan INC', 'shared_tokens': {'allergan'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000884629, Allergan Finance LLC

  xvar xval
0 AssetsCurrent 2,569,700,000
1 IntangibleAssetsNetIncludingGoodwill 3,321,900,000
2 PropertyPlantAndEquipmentNet 713,700,000
3 remainder_Assets 93,000,000
4 LiabilitiesCurrent 1,839,500,000
5 LiabilitiesNoncurrent 921,200,000
6 remainder_Liabilities 375,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 353,100,000
9 ResearchAndDevelopmentExpense 295,400,000
10 remainder_Expenses 3,596,600,000
11 remainder_Revenues 4,584,400,000
12 remainder_NetIncome -80,200,000
13 remainder_ComprehensiveNetIncome -72,200,000
  yvar yval
0 Assets 6,698,300,000
1 Liabilities 3,135,800,000
2 Expenses 4,245,100,000
3 Revenues 4,584,400,000
4 StockholdersEquity 3,562,500,000
5 NetIncome 259,100,000
6 ComprehensiveNetIncome 223,000,000
7 BaseVar 9,408,000,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.62
9 EconomicCapitalRatio 2.77

Edgar->Model Mapping

Feature Distribution

Change over Time